Eli Lilly reports weight losses topping 20 percent with new anti-obesity drug - The Hill

Eli Lilly in a statement to investors is saying that its new experimental anti-obesity drug has caused patients in a clinical trail to lose up to 20 percent of their weight.  The test group included 2,539 participants, and was meant to test the safety and eff…

Eli Lilly in a statement to investors is saying that its new experimental anti-obesity drug has caused patients in a clinical trail to lose up to 20 percent of their weight.  The test group included… [+1971 chars]

full article...